NEUP vs. WGRX
NEUP (Neuphoria Therapeutics Inc) and WGRX (Wellgistics Health, Inc) are both stocks. Both are in the Healthcare sector — NEUP in Biotechnology, WGRX in Pharmaceutical Retailers. Over the past year, NEUP returned -37.20% vs -95.00% for WGRX. At a 0.09 correlation, their price movements are largely independent.
Performance
NEUP vs. WGRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NEUP achieves a 15.72% return, which is significantly higher than WGRX's -78.22% return.
NEUP
- 1D
- -7.23%
- 1M
- -16.54%
- YTD
- 15.72%
- 6M
- 5.15%
- 1Y
- -37.20%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
WGRX
- 1D
- 1.40%
- 1M
- -6.45%
- YTD
- -78.22%
- 6M
- -84.65%
- 1Y
- -95.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
NEUP vs. WGRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
NEUP Neuphoria Therapeutics Inc | 15.72% | -20.49% |
WGRX Wellgistics Health, Inc | -78.22% | -89.51% |
Correlation
The correlation between NEUP and WGRX is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Feb 24, 2025 | 0.09 |
Fundamentals
NEUP:
$24.30M
WGRX:
$455.10M
NEUP:
-$113.42
WGRX:
-$0.98
NEUP:
-$15.66M
WGRX:
$14.03M
NEUP:
-$15.75M
WGRX:
-$10.16M
NEUP:
-$865.47M
WGRX:
-$53.11M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NEUP vs. WGRX — Risk / Return Rank
NEUP
WGRX
NEUP vs. WGRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Neuphoria Therapeutics Inc (NEUP) and Wellgistics Health, Inc (WGRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NEUP | WGRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.06 | ||
| Sortino ratioReturn per unit of downside risk | +1.20 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 0.94 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | -0.46 | -0.99 | +0.53 |
| Martin ratioReturn relative to average drawdown | -0.60 | -1.34 | +0.74 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NEUP | WGRX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.30 | -0.36 | +0.06 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.45 | -0.38 | -0.07 |
Drawdowns
NEUP vs. WGRX - Drawdown Comparison
The maximum NEUP drawdown since its inception was -96.32%, roughly equal to the maximum WGRX drawdown of -98.73%. Use the drawdown chart below to compare losses from any high point for NEUP and WGRX.
Loading charts...
Drawdown Indicators
| NEUP | WGRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.32% | -98.73% | +2.41% |
Max Drawdown (1Y)Largest decline over 1 year | -81.40% | -96.41% | +15.01% |
Current DrawdownCurrent decline from peak | -94.36% | -98.25% | +3.89% |
Average DrawdownAverage peak-to-trough decline | -91.95% | -74.98% | -16.97% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 61.78% | 70.85% | -9.07% |
Volatility
NEUP vs. WGRX - Volatility Comparison
The current volatility for Neuphoria Therapeutics Inc (NEUP) is 17.62%, while Wellgistics Health, Inc (WGRX) has a volatility of 97.65%. This indicates that NEUP experiences smaller price fluctuations and is considered to be less risky than WGRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NEUP | WGRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.62% | 97.65% | -80.03% |
Volatility (6M)Calculated over the trailing 6-month period | 34.52% | 118.74% | -84.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 124.55% | 267.00% | -142.45% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 171.50% | 250.47% | -78.97% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 171.50% | 250.47% | -78.97% |
Dividends
NEUP vs. WGRX - Dividend Comparison
Neither NEUP nor WGRX has paid dividends to shareholders.
Financials
NEUP vs. WGRX - Financials Comparison
This section allows you to compare key financial metrics between Neuphoria Therapeutics Inc and Wellgistics Health, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NEUP and WGRX have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
WGRX has higher volatility (97.65%) compared to NEUP (17.62%). In terms of maximum drawdown, NEUP dropped -96.32% vs WGRX's -98.73%.
NEUP currently has the higher Sharpe Ratio (-0.30 vs -0.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NEUP and WGRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer